Michael McDonnell

Mike has decades of executive finance experience, including nearly 25 years serving as a Chief Financial Officer in a variety of companies. These companies include Fortune 500 companies such as EchoStar Communications/DISH Network (NASDAQ: DISH), IQVIA (NYSE: IQV), and Biogen (NASDAQ: BIIB). During his years as a CFO, Mike participated in over $35 billion of capital markets transactions, inclusive of an Initial Public Offering. He has also participated in over 70 acquisitions, from small tuck-ins to up to $7.3 billion. Mike has had direct operational oversight of Corporate Development/M&A, Financial Planning and Analysis, Treasury, Investor Relations, Internal Audit, Procurement, and Information Technology. Mike also played a lead role in Biogen's $1B "Fit for Growth" cost reduction program. Prior to becoming a CFO, Mike worked for 14 years in the audit practice at PricewaterhouseCoopers, four years of which he was a Partner. He has served as a Director on the Boards of five public companies and has served as an Audit Committee Chair. He currently serves on the Boards of Baxter International, Merit Medical Systems, and Moderna, and is a Member of the Finance Committee of Atlantic Health System. Mike has a Bachelor of Science degree from Georgetown University, where he majored in Accounting and played football.